Marta Roman
Majorstuen, 0304, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.
Journal: Nature communications
Published: December 13, 2022
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Journal: Nature communications
Published: May 27, 2022
Interval Breast Cancer Rates and Histopathologic Tumor Characteristics after False-Positive Findings at Mammography in a Population-based Screening Program.
Journal: Radiology
Published: December 15, 2017
Comparison of subjective and fully automated methods for measuring mammographic density.
Journal: Acta radiologica (Stockholm, Sweden : 1987)
Published: June 02, 2017
Breast compression parameters and mammographic density in the Norwegian Breast Cancer Screening Programme.
Journal: European radiology
Published: January 30, 2017
Postmenopausal Hormone Therapy and Breast Cancer Prognostic Characteristics: A Linkage between Nationwide Registries.
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: March 24, 2016
Risk of breast cancer after false-positive results in mammographic screening.
Journal: Cancer medicine
Published: August 28, 2015
Cross-national comparison of screening mammography accuracy measures in U.S., Norway, and Spain.
Journal: European radiology
Published: June 12, 2015
Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program.
Journal: European journal of radiology
Published: May 15, 2015
Mammographic density and histopathologic characteristics of screen-detected tumors in the Norwegian Breast Cancer Screening Program.
Journal: Acta radiologica open
Published: May 06, 2015
Last Updated: 09/26/2026